Mashlika Prasanth
Senior Research Officer, Neuroscience Johnson & Johnson
Seminars
Thursday 10th December 2026
Incorporating Novel Biomarkers into Routine Testing for Earlier, Presymptomatic Detection of Neurodevelopmental & Neuro-Oncology Indications
4:00 pm
- Case study 1: Leveraging protein factors found specifically in amniotic fluid todetect autism prior to third trimester
- Case study 2: Utilizing CRISPR technology to identify markers present before the onset of glioblastoma
